Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Invested Capital (2020 - 2025)

Ironwood Pharmaceuticals' Return on Invested Capital history spans 6 years, with the latest figure at 0.24% for Q3 2025.

  • For Q3 2025, Return on Invested Capital rose 372.0% year-over-year to 0.24%; the TTM value through Sep 2025 reached 0.24%, up 372.0%, while the annual FY2025 figure was 0.06%, 6.0% down from the prior year.
  • Return on Invested Capital for Q3 2025 was 0.24% at Ironwood Pharmaceuticals, down from 0.2% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 6.74% in Q3 2023 and bottomed at 5.94% in Q2 2024.
  • The 5-year median for Return on Invested Capital is 0.32% (2022), against an average of 0.12%.
  • The largest annual shift saw Return on Invested Capital soared 643bps in 2023 before it tumbled -1070bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.86% in 2021, then plummeted by -55bps to 0.38% in 2022, then plummeted by -178bps to 0.3% in 2023, then soared by 99bps to 0.0% in 2024, then plummeted by -5389bps to 0.24% in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Return on Invested Capital are 0.24% (Q3 2025), 0.2% (Q2 2025), and 0.0% (Q4 2024).